Your shopping cart is currently empty

USP1-IN-4 (compound 10) serves as a potent inhibitor of USP1, exhibiting an IC 50 of 2.44 nM. It demonstrates anticancer properties and operates synergistically with various anticancer drugs [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | USP1-IN-4 (compound 10) serves as a potent inhibitor of USP1, exhibiting an IC 50 of 2.44 nM. It demonstrates anticancer properties and operates synergistically with various anticancer drugs [1]. |
| Targets&IC50 | USP1:2.44 nM |
| In vitro | USP1-IN-4, at concentrations ranging from 0.0005 to 10 μM, significantly inhibits USP1/UAF1 activity with an IC50 of 2.44 nM following a 15-minute treatment [1]. Additionally, USP1-IN-4 impedes the growth of MDA-MB-436 cells over a 7-day period, also within the 0.0005 to 10 μM range, yielding an IC50 of 103.75 nM [1]. In a cell viability assay using the MDA-MB-436 cell line, a concentration range of 0.0005 to 10 μM was used, and cell growth inhibition was observed with an IC50 of 103.75 nM. |
| Molecular Weight | 476.50 |
| Formula | C26H23F3N6 |
| Cas No. | 2878441-72-4 |
| Smiles | C(C=1N2C(C=NC(=N2)C3=C(C(C)C)C=CC=C3)=CN1)C4=CC=C(C=C4)C5=NC(C(F)(F)F)=CN5C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.